ICM
G icon

Invenomic Capital Management’s Genpact G Stock Holding History

Invenomic Capital Management’s Portfolio G Stock Details G Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-217,842
Closed -$7.01M – 159
2024
Q2 		$7.01M Buy
+217,842
New +$7.03M 0.34% 86

Other funds holding G

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIEF
Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Invenomic Capital Management's G Position: Q3 2024 in Review

Invenomic Capital Management sold out of Genpact (G) in Q3 2024, closing a stake of 217,842 shares — an estimated $7.01M sold.

Invenomic Capital Management first reported a position in G in Q2 2024 and held it in 1 quarter. The position peaked at $7.01M in Q2 2024. 385 funds tracked by Wall St. Rank hold G as of Q3 2024.

  • Invenomic Capital Management reported no remaining Genpact position as of Q3 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 217,842 Genpact shares in Q3 2024, an estimated $7.01M.
  • Invenomic Capital Management first reported a position in Genpact in Q2 2024 and held it in 1 quarter.
  • Invenomic Capital Management's Genpact position peaked at $7.01M in Q2 2024.
  • 385 funds tracked by Wall St. Rank held Genpact as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.